BALA CYNWYD, Pa.--(BUSINESS WIRE)--
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Omnicare, Inc.
("Omnicare" or "the Company") (NYSE: OCR) for possible breaches of
fiduciary duty and other violations of state law in connection with the
sale of the Company to CVS Health Corporation, Inc. ("CVS").
Click here to learn more about the investigation http://brodsky-smith.com/941-ocr-omnicare-inc.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Omnicare shareholders will receive
only $98.00 in cash for each share of Omnicare stock they own. The
investigation concerns whether the Board of Omnicare breached their
fiduciary duties to shareholders and whether CVS is underpaying for
Omnicare. The transaction may undervalue Omnicare as the Company has had
20% annual increases in revenue from its specialty unit, which provides
services that support drug makers, distributors and health professionals
who care for patients with complex diseases. Thereby, allowing CVS to
expand significantly in the assisted-living market, which is expected to
grow markedly. In addition, an analyst has placed a $104.00 per share
price target on Omnicare stock.
If you own shares of Omnicare and wish to discuss the legal
ramifications of the investigation, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions. You may
contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky &
Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by
visiting http://brodsky-smith.com/941-ocr-omnicare-inc.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise
representing shareholders throughout the nation in securities and class
action lawsuits. The attorneys at Brodsky & Smith have been appointed by
numerous courts throughout the country to serve as lead counsel in class
actions and have successfully recovered millions of dollars for our
clients and shareholders. Attorney advertising. Prior results do not
guarantee a similar outcome.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150527005344/en/
